Literature DB >> 9362

Humoral immunity to Streptococcus pneumoniae induced by a pneumococcal ribosomal protein fraction.

C L Swendsen, W Johnson.   

Abstract

Isolation of a protective subfraction of ribosomes from Streptococcus pneumoniae has been achieved, and the immune response it induces has been investigated. Mice immunized with pneumococcal ribosomes or purified protein extracted from the ribosomal preparation (2-CE protein) exhibit similar survival rates upon challenge by virulent S. pneumoniae. In contrast, recipients of purified ribosomal ribonucleic acid were never protected against pneumococcal challenge. Serum from mice immunized with pneumococcal ribosomes or 2-CE protein passively immunized syngeneic recipients against pneumococcal challenge, whereas spleen cells from the same donors were unable to transfer immunity. Passive immunization with antiribosome serum could be abrogated by absorption with whole ribosomes, 2-CE protein, or various serotypes of S. pneumoniae (capsular types 2, 3, 6, and 14). Antiribosome serum significantly enhanced clearance of S. pneumoniae from mouse blood in vivo and in vitro. This required phagocytic cells, since antiribosome serum alone, with or without complement, supported growth of S. pneumoniae to an extent comparable to normal serum. The data suggest that the primary immunogen of pneumococcal ribosomes resides in the protein fraction. Further, the immunity induced by the protein fraction is mediated by antibody that appears to function as an opsonin for S. pneumoniae.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 9362      PMCID: PMC420889          DOI: 10.1128/iai.14.2.345-354.1976

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  34 in total

1.  Bacterial growth inhibition by amniotic fluid. III. Demonstration of the variability of bacterial growth inhibition by amniotic fluid with a new plate-count technique.

Authors:  P Schlievert; B Larsen; W Johnson; R P Galask
Journal:  Am J Obstet Gynecol       Date:  1975-08-01       Impact factor: 8.661

2.  Biological properties of an immunogenic pneumococcal subcellular preparation.

Authors:  H C Thompson; T K Eisenstein
Journal:  Infect Immun       Date:  1976-03       Impact factor: 3.441

3.  Immunological reactions with chromic chloride-treated erythrocytes.

Authors:  W P Faulk; V Houba
Journal:  J Immunol Methods       Date:  1973-08       Impact factor: 2.303

4.  The effect of lymphocyte supernatant fluids on the intracellular growth of virulent tubercle bacilli.

Authors:  C L Klun; G P Youmans
Journal:  J Reticuloendothel Soc       Date:  1973-03

5.  Evidence for O antigens as the antigenic determinants in "ribosomal" vaccines prepared from Salmonella.

Authors:  T K Eisenstein
Journal:  Infect Immun       Date:  1975-08       Impact factor: 3.441

6.  Biochemical and immunological properties of ribonucleic acid-rich extracts from Francisella tularensis.

Authors:  I I Andron LA; H T Eigelsbach
Journal:  Infect Immun       Date:  1975-07       Impact factor: 3.441

7.  Ribosomal vaccines. II. Specificity of the immune response to ribosomal ribonucleic acid and protein isolated from Salmonella typhimurium.

Authors:  W Johnson
Journal:  Infect Immun       Date:  1973-09       Impact factor: 3.441

8.  Immunogenicity of ribosomal vaccines isolated from group A, type 14 Streptococcus pyogenes.

Authors:  W O Schalla; W Johnson
Journal:  Infect Immun       Date:  1975-06       Impact factor: 3.441

9.  The adjuvant activity of mycobacterial RNA preparations and synthetic polynucleotides for induction of delayed hypersensitivity to purified protein derivative in guinea pigs.

Authors:  C H Casavant; G P Youmans
Journal:  J Immunol       Date:  1975-03       Impact factor: 5.422

10.  Efficacy of ribosomal preparations from Pseudomonas aeruginosa to protect against intravenous Pseudomonas challenge in mice.

Authors:  R L Smith; J A Wysocki; J N Bruun; S J De Courcy; W S Blakemore; S Mudd
Journal:  J Reticuloendothel Soc       Date:  1974-01
View more
  22 in total

1.  Immuno-stimulation by a ribosomal vaccine associated with a bacterial cell wall adjuvant in humans.

Authors:  F B Michel; L Dussourd D'Hinterland; J Bousquet; A M Pinel; G Normier
Journal:  Infect Immun       Date:  1978-06       Impact factor: 3.441

2.  Immunogenicity of ribosomes from enzymatically lysed Streptococcus pyogenes.

Authors:  B A Green; W Johnson
Journal:  Infect Immun       Date:  1980-02       Impact factor: 3.441

3.  Characterization of the immunoprotective antigen of ribosomal preparations from Haemophilus influenzae.

Authors:  R P Tewari; M Lynn; A J Birnbaum; M Solotorovsky
Journal:  Infect Immun       Date:  1978-01       Impact factor: 3.441

4.  Immunoprotective activity of ribosomes from Haemophilus influenzae.

Authors:  M Lynn; R P Tewari; M Solotorovsky
Journal:  Infect Immun       Date:  1977-02       Impact factor: 3.441

5.  Direct evidence for the presence of lipopolysaccharide components in Pseudomonas ribosomal vaccine.

Authors:  M M Lieberman
Journal:  Infect Immun       Date:  1977-08       Impact factor: 3.441

6.  Nature of the cross-protective antigen in subcellular vaccines of Streptococcus pneumoniae.

Authors:  C C Au; T K Eisenstein
Journal:  Infect Immun       Date:  1981-01       Impact factor: 3.441

7.  Capsular serotypic specificity of the protection conferred on mice by Klebsiella pneumoniae ribosomal preparations.

Authors:  M Riottot; J M Fournier; J Pillot
Journal:  Infect Immun       Date:  1979-05       Impact factor: 3.441

8.  A Streptococcus mutans immunogen that reacts equally with S. mutans antibody of all serotypes.

Authors:  D L Everhart; L M Miglietta; V A Maresca; P Kelly-Hatfield
Journal:  Med Microbiol Immunol       Date:  1984       Impact factor: 3.402

9.  Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system.

Authors:  J Sutcliffe; A Tait-Kamradt; L Wondrack
Journal:  Antimicrob Agents Chemother       Date:  1996-08       Impact factor: 5.191

10.  Humoral and cell-mediated responses to a ribosomal preparation from Streptococcus mutans.

Authors:  R L Gregory; I L Shechmeister
Journal:  Infect Immun       Date:  1982-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.